메뉴 건너뛰기
Scientia Pharmaceutica
Volumn 81, Issue 2, 2013, Pages 591-606
Preparation and in Vitro/Ex Vivo evaluation of moxifloxacin-loaded PLGA nanosuspensions for ophthalmic application
Author keywords

Goat cornea; Korsemeyer peppas; Moxifloxacin; Nanosuspension; Ocular; PLGA
Indexed keywords

MOXIFLOXACIN; POLYGLACTIN;
EID: 84879294394     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1204-16     Document Type: Article
Times cited : (79)
References (38)
  • 1
    • 24044538535 scopus 로고    scopus 로고
    • Vinylpyrrolidone-co-(meth) acrylic acid inserts for ocular drug delivery: Synthesis and evaluation
    • Barbu E, Sarvaiya I, Green KL, Nevell TG, Tsibouklis J. Vinylpyrrolidone-co-(meth) acrylic acid inserts for ocular drug delivery: synthesis and evaluation. J Biomed Mater Res A. 2005; 74: 598-606. http://dx.doi.org/10.1002/jbm.a.30329
    • (2005) J Biomed Mater Res A , vol.74 , pp. 598-606
    • Barbu, E.1    Sarvaiya, I.2    Green, K.L.3    Nevell, T.G.4    Tsibouklis, J.5
  • 2
    • 0034018474 scopus 로고    scopus 로고
    • Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers
    • Gangopadhyay N, Daniell M, Weih L, Taylor HR. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Br J Ophthalmol. 2000; 84: 378-384. http://dx.doi.org/10.1136/bjo.84.4.378
    • (2000) Br J Ophthalmol , vol.84 , pp. 378-384
    • Gangopadhyay, N.1    Daniell, M.2    Weih, L.3    Taylor, H.R.4
  • 3
    • 77949917853 scopus 로고    scopus 로고
    • Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery
    • Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine. 2010; 6: 324-333. http://dx.doi.org/10.1016/j.nano.2009.10.004
    • (2010) Nanomedicine , vol.6 , pp. 324-333
    • Gupta, H.1    Aqil, M.2    Khar, R.K.3    Ali, A.4    Bhatnagar, A.5    Mittal, G.6
  • 4
    • 0035859983 scopus 로고    scopus 로고
    • Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface
    • De Campos AM, Sanchez A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm. 2001; 224: 159-168. http://dx.doi.org/10.1016/S0378-5173(01)00760-8
    • (2001) Application to Cyclosporin A. Int J Pharm , vol.224 , pp. 159-168
    • de Campos, A.M.1    Sanchez, A.2    Alonso, M.J.3
  • 6
    • 0034017776 scopus 로고    scopus 로고
    • Intracellular targets of moxacifloxacin: A comparison with other fluoroquinolones
    • Pestova E, Millichap JJ, Noskin GA, Peterson LR. Intracellular targets of moxacifloxacin: a comparison with other fluoroquinolones. J Antimicrob Chemother. 2000; 45: 583-590. http://dx.doi.org/10.1093/jac/45.5.583
    • (2000) J Antimicrob Chemother , vol.45 , pp. 583-590
    • Pestova, E.1    Millichap, J.J.2    Noskin, G.A.3    Peterson, L.R.4
  • 7
    • 2542498885 scopus 로고    scopus 로고
    • Effectiveness of ciprofloxacin, levofloxacin or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis
    • Dajcs JJ, Thibodeaux BA, Marquart ME, Girgis DO, Traiedj M, O'Callaghan RJ. Effectiveness of ciprofloxacin, levofloxacin or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis. Antimicrob Agents Chemother. 2004; 48: 1948-1952. http://dx.doi.org/10.1128/AAC.48.6.1948-1952.2004
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 1948-1952
    • Dajcs, J.J.1    Thibodeaux, B.A.2    Marquart, M.E.3    Girgis, D.O.4    Traiedj, M.5    O'Callaghan, R.J.6
  • 8
    • 34447562795 scopus 로고    scopus 로고
    • Penetration of second-, third-, and fourth generation topical fluroroquinolone into aqueous and vitrous humor in a rabbit endophtalmitis model
    • Yagci R, Oflu Y, Dincel A, Kaya E, Yagci S, Bayer B, Duman S, Bozkurt A. Penetration of second-, third-, and fourth generation topical fluroroquinolone into aqueous and vitrous humor in a rabbit endophtalmitis model. Eye (Lond). 2007; 21: 990-994. http://dx.doi.org/10.1038/sj.eye.6702414
    • (2007) Eye (Lond) , vol.21 , pp. 990-994
    • Yagci, R.1    Oflu, Y.2    Dincel, A.3    Kaya, E.4    Yagci, S.5    Bayer, B.6    Duman, S.7    Bozkurt, A.8
  • 9
    • 79957490620 scopus 로고    scopus 로고
    • Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies
    • Aksungur P, Demirbilek M, Denkbas EB, Vandervoort J, Ludwig A, Unlu N. Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies. J Control Release. 2011; 151: 286-294. http://dx.doi.org/10.1016/j.jconrel.2011.01.010
    • (2011) J Control Release , vol.151 , pp. 286-294
    • Aksungur, P.1    Demirbilek, M.2    Denkbas, E.B.3    Vandervoort, J.4    Ludwig, A.5    Unlu, N.6
  • 11
    • 78651089761 scopus 로고    scopus 로고
    • Development of mucoadhesive poly (lactide-co-glycolide) nanoparticles for ocular application
    • Yoncheva K, Vandervoort J, Ludwig A. Development of mucoadhesive poly (lactide-co-glycolide) nanoparticles for ocular application. Pharm Dev Technol. 2011; 16: 29-35. http://dx.doi.org/10.3109/10837450903479954
    • (2011) Pharm Dev Technol , vol.16 , pp. 29-35
    • Yoncheva, K.1    Vandervoort, J.2    Ludwig, A.3
  • 12
    • 1842789742 scopus 로고    scopus 로고
    • Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles
    • Dillen K, Vandervoort J, Van den Mooter G, Verheyden L, Ludwig A. Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int J Pharm. 2004; 275: 171-187. http://dx.doi.org/10.1016/j.ijpharm.2004.01.033
    • (2004) Int J Pharm , vol.275 , pp. 171-187
    • Dillen, K.1    Vandervoort, J.2    Van den Mooter, G.3    Verheyden, L.4    Ludwig, A.5
  • 13
    • 59949091205 scopus 로고    scopus 로고
    • Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application
    • Agnihotri SM, Vavia PR. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomedicine. 2009; 5: 90-95. http://dx.doi.org/10.1016/j.nano.2008.07.003
    • (2009) Nanomedicine , vol.5 , pp. 90-95
    • Agnihotri, S.M.1    Vavia, P.R.2
  • 14
    • 33645462293 scopus 로고    scopus 로고
    • Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene
    • Pignatello R, Ricupero N, Bucolo C, Maugeri F, Maltese A, Puglisi G. Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene. AAPS Pharm Sci Tech. 2006; 7: E27. http://dx.doi.org/10.1208/pt070127
    • (2006) AAPS Pharm Sci Tech , vol.7
    • Pignatello, R.1    Ricupero, N.2    Bucolo, C.3    Maugeri, F.4    Maltese, A.5    Puglisi, G.6
  • 15
    • 78650339231 scopus 로고    scopus 로고
    • Sulfacetamide Loaded Eudragit RL 100 Nanosuspension with Potential for Ocular Delivery
    • Mandal B, Alexander KS, Riga AT. Sulfacetamide Loaded Eudragit RL 100 Nanosuspension with Potential for Ocular Delivery. J Pharm Pharm Sci. 2010; 13: 510-523. http://www.ncbi.nlm.nih.gov/pubmed/21486528
    • (2010) J Pharm Pharm Sci , vol.13 , pp. 510-523
    • Mandal, B.1    Alexander, K.S.2    Riga, A.T.3
  • 16
    • 34447516995 scopus 로고    scopus 로고
    • Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis
    • Adibkia K, Siahi Shadbad MR, Nokhodchi A, Javadzedeh A, Barzegar-Jalali M, Barar J, Mohammadi G, Omidi Y. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis. J Drug Target. 2007; 15: 407-416. http://dx.doi.org/10.1080/10611860701453125
    • (2007) J Drug Target , vol.15 , pp. 407-416
    • Adibkia, K.1    Siahi, S.M.R.2    Nokhodchi, A.3    Javadzedeh, A.4    Barzegar-Jalali, M.5    Barar, J.6    Mohammadi, G.7    Omidi, Y.8
  • 17
    • 79952768867 scopus 로고    scopus 로고
    • Nanosuspension: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B
    • Das S, Suresh PK. Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B. Nanomedicine. 2011; 7: 242-247. http://dx.doi.org/10.1016/j.nano.2010.07.003
    • (2011) Nanomedicine , vol.7 , pp. 242-247
    • Das, S.1    Suresh, P.K.2
  • 18
    • 0036020063 scopus 로고    scopus 로고
    • Eudragit RS 100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen
    • Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G. Eudragit RS 100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci. 2002; 16: 53-61. http://dx.doi.org/10.1016/S0928-0987(02)00057-X
    • (2002) Eur J Pharm Sci , vol.16 , pp. 53-61
    • Pignatello, R.1    Bucolo, C.2    Ferrara, P.3    Maltese, A.4    Puleo, A.5    Puglisi, G.6
  • 19
    • 0035999781 scopus 로고    scopus 로고
    • Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application
    • Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials. 2002; 23: 3247-3255. http://dx.doi.org/10.1016/S0142-9612(02)00080-7
    • (2002) Biomaterials , vol.23 , pp. 3247-3255
    • Pignatello, R.1    Bucolo, C.2    Spedalieri, G.3    Maltese, A.4    Puglisi, G.5
  • 20
    • 0041882155 scopus 로고    scopus 로고
    • Preparation of polymeric nanoparticles containing corticosteroid by a novel aerosol flow reactor method
    • Eerikainen H, Kauppinen El. Preparation of polymeric nanoparticles containing corticosteroid by a novel aerosol flow reactor method. Int J Pharm. 2003; 263: 69-83. http://dx.doi.org/10.1016/S0378-5173(03)00370-3
    • (2003) Int J Pharm , vol.263 , pp. 69-83
    • Eerikainen, H.1    El, K.2
  • 21
    • 78650445731 scopus 로고    scopus 로고
    • Diclofenc-loaded eudragit S100 nanosuspension for ophthalmic delivery
    • Ahuja M, Dhake AS, Sharma SK, Majumdar DK. Diclofenc-loaded eudragit S100 nanosuspension for ophthalmic delivery. J Microencapsul. 2011; 28: 37-45. http://dx.doi.org/10.3109/02652048.2010.523794
    • (2011) J Microencapsul , vol.28 , pp. 37-45
    • Ahuja, M.1    Dhake, A.S.2    Sharma, S.K.3    Majumdar, D.K.4
  • 22
    • 36749063612 scopus 로고    scopus 로고
    • Chitosan nanoparticles for prolonged delivery of timolol maleate
    • Agnihotri SA, Aminabhavi TM. Chitosan nanoparticles for prolonged delivery of timolol maleate. Drug Dev Ind Pharm. 2007; 33: 1254-1262. http://dx.doi.org/10.1080/03639040701384942
    • (2007) Drug Dev Ind Pharm , vol.33 , pp. 1254-1262
    • Agnihotri, S.A.1    Aminabhavi, T.M.2
  • 23
    • 0029347475 scopus 로고
    • Microspheres and nanoparticles used in ocular delivery systems
    • Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev. 1995; 16: 61-73. http://dx.doi.org/10.1016/0169-409X(95)00017-2
    • (1995) Adv Drug Deliv Rev , vol.16 , pp. 61-73
    • Zimmer, A.1    Kreuter, J.2
  • 24
    • 0034580371 scopus 로고    scopus 로고
    • The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices
    • Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials. 2000; 21: 2475-2490. http://dx.doi.org/10.1016/S0142-9612(00)00115-0
    • (2000) Biomaterials , vol.21 , pp. 2475-2490
    • Jain, R.A.1
  • 25
    • 1442310826 scopus 로고    scopus 로고
    • Preparation and evaluation of drug-loaded gelatine nanoparticles for topical ophthalmic use
    • Vandervoort J, Ludwig A. Preparation and evaluation of drug-loaded gelatine nanoparticles for topical ophthalmic use. Eur J Pharm Biopharm. 2004; 57: 251-261. http://dx.doi.org/10.1016/S0939-6411(03)00187-5
    • (2004) Eur J Pharm Biopharm , vol.57 , pp. 251-261
    • Vandervoort, J.1    Ludwig, A.2
  • 26
  • 27
    • 77953138951 scopus 로고    scopus 로고
    • Preparation and evaluation of nanoparticles of gum cordia, an anionic polysaccharide for ophthalmic delivery
    • Yadav M, Ahuja M. Preparation and evaluation of nanoparticles of gum cordia, an anionic polysaccharide for ophthalmic delivery. Carbohydrate Polymers. 2010; 81: 871-877. http://dx.doi.org/10.1016/j.carbpol.2010.03.065
    • (2010) Carbohydrate Polymers , vol.81 , pp. 871-877
    • Yadav, M.1    Ahuja, M.2
  • 28
    • 39849100697 scopus 로고    scopus 로고
    • Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimisation and in vitro characterisation
    • Motwani SK, Chopra S, Talegaonkar S, Kohli K, Ahmad FJ, Khar RK. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm. 2008; 68: 513-525. http://dx.doi.org/10.1016/j.ejpb.2007.09.009
    • (2008) Eur J Pharm Biopharm , vol.68 , pp. 513-525
    • Motwani, S.K.1    Chopra, S.2    Talegaonkar, S.3    Kohli, K.4    Ahmad, F.J.5    Khar, R.K.6
  • 29
    • 79958842065 scopus 로고    scopus 로고
    • Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery
    • Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. J Drug Target. 2011; 19: 409-417. http://dx.doi.org/10.3109/1061186X.2010.504268
    • (2011) J Drug Target , vol.19 , pp. 409-417
    • Gupta, H.1    Aqil, M.2    Khar, R.K.3    Ali, A.4    Bhatnagar, A.5    Mittal, G.6
  • 30
    • 0032952283 scopus 로고    scopus 로고
    • PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug
    • Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release. 1999; 57: 171-185. http://dx.doi.org/10.1016/S0168-3659(98)00116-3
    • (1999) J Control Release , vol.57 , pp. 171-185
    • Govender, T.1    Stolnik, S.2    Garnett, M.C.3    Illum, L.4    Davis, S.S.5
  • 31
    • 0019151971 scopus 로고
    • Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits
    • Schoenwald RD, Stewart P. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits. J Pharm Sci. 1980; 69: 391-394. http://dx.doi.org/10.1002/jps.2600690407
    • (1980) J Pharm Sci , vol.69 , pp. 391-394
    • Schoenwald, R.D.1    Stewart, P.2
  • 32
    • 0036176196 scopus 로고    scopus 로고
    • Production and characterization of a budenoside nanosuspension for pulmonary administration
    • Jacobs C, Muller RH. Production and characterization of a budenoside nanosuspension for pulmonary administration. Pharm Res. 2002; 19: 189-194. http://dx.doi.org/10.1023/A:1014276917363
    • (2002) Pharm Res , vol.19 , pp. 189-194
    • Jacobs, C.1    Muller, R.H.2
  • 33
    • 0035848417 scopus 로고    scopus 로고
    • Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers
    • Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release. 2001; 71: 53-69. http://dx.doi.org/10.1016/S0168-3659(00)00364-3
    • (2001) J Control Release , Issue.71 , pp. 53-69
    • Feng, S.1    Huang, G.2
  • 34
    • 57349134515 scopus 로고    scopus 로고
    • PLGA nanospheres for the ocular delivery of flurbiprofen: Drug release and interactions
    • Vega E, Gamisans F, Garcia ML, Chauvet A, Lacoulonche F, Egea MA. PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions. J Pharm Sci. 2008; 97: 5306-5317. http://dx.doi.org/10.1002/jps.21383
    • (2008) J Pharm Sci , vol.97 , pp. 5306-5317
    • Vega, E.1    Gamisans, F.2    Garcia, M.L.3    Chauvet, A.4    Lacoulonche, F.5    Egea, M.A.6
  • 35
    • 0021904208 scopus 로고
    • Analysis of fickian and non-fickian drug release from polymers
    • Peppas NA. Analysis of fickian and non-fickian drug release from polymers. Pharm Acta Helv. 1985; 60: 110-111. http://www.ncbi.nlm.nih.gov/pubmed/4011621
    • (1985) Pharm Acta Helv , vol.60 , pp. 110-111
    • Peppas, N.A.1
  • 36
    • 0021052458 scopus 로고
    • Huang HS. Corneal penetration behavior of beta-blocking agents. I. physicochemical factors
    • Schoenwald RD, Huang HS. Corneal penetration behavior of beta-blocking agents. I. physicochemical factors. J Pharm Sci. 1983; 72: 1266-1272. http://dx.doi.org/10.1002/jps.2600721108
    • (1983) J Pharm Sci , vol.72 , pp. 1266-1272
    • Schoenwald, R.D.1
  • 37
    • 0030152390 scopus 로고    scopus 로고
    • The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of Streptococci
    • Biedenbach DJ, Jones RN. The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of Streptococci. Diagn Microbiol Infect Dis. 1996; 25: 47-51. http://dx.doi.org/10.1016/0732-8893(96)00066-1
    • (1996) Diagn Microbiol Infect Dis , vol.25 , pp. 47-51
    • Biedenbach, D.J.1    Jones, R.N.2
  • 38
    • 0028266514 scopus 로고
    • Levofloxacin: A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy
    • Davis R, Bryson HM. Levofloxacin: a review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs. 1994; 47: 677-700. http://dx.doi.org/10.2165/00003495-199447040-00008
    • (1994) Drugs , vol.47 , pp. 677-700
    • Davis, R.1    Bryson, H.M.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.